MedTrace Logo

Skin Barrier and Microbiome of CTCL Patients

NCT05827107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2025-06-15

No results posted yet for this study

Summary

The goal of this study is to investigate the microbiome composition of the nares, non-lesional skin and patches, plaques and tumours in lesional skin of CTCL patients, including all stages of the disease, and to correlate microbiome (including S. aureus presence) and disease severity from CTCL patients.

Conditions

  • Lymphoma, T-Cell, Cutaneous

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Micreos

    collaborator UNKNOWN

  • Centre for Human Drug Research, Netherlands

    lead OTHER

Principal Investigators

  • Robert Rissmann, PhD · Centre for Human Drug Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05827107 on ClinicalTrials.gov